Your browser doesn't support javascript.
Tracking the incidence and risk factors for SARS-CoV-2 infection using historical maternal booking serum samples.
Mullins, Edward; McCabe, Ruth; Bird, Sheila M; Randell, Paul; Pond, Marcus J; Regan, Lesley; Parker, Eleanor; McClure, Myra; Donnelly, Christl A.
  • Mullins E; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom.
  • McCabe R; The George Institute for Global Health, Queen Charlotte's and Chelsea Hospital, London, United Kingdom.
  • Bird SM; Department of Statistics, University of Oxford, Oxford, United Kingdom.
  • Randell P; NIHR Health Research Protection Unit in Emerging and Zoonotic Infections, University of Liverpool, Liverpool, United Kingdom.
  • Pond MJ; MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.
  • Regan L; College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom.
  • Parker E; Department of Infection and Immunity, North West London Pathology, London, United Kingdom.
  • McClure M; Department of Infection and Immunity, North West London Pathology, London, United Kingdom.
  • Donnelly CA; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom.
PLoS One ; 17(9): e0273966, 2022.
Article in English | MEDLINE | ID: covidwho-2009716
ABSTRACT
The early transmission dynamics of SARS-CoV-2 in the UK are unknown but their investigation is critical to aid future pandemic planning. We tested over 11,000 anonymised, stored historic antenatal serum samples, given at two north-west London NHS trusts in 2019 and 2020, for total antibody to SARS-CoV-2 receptor binding domain (anti-RBD). Estimated prevalence of seroreactivity increased from 1% prior to mid-February 2020 to 17% in September 2020. Our results show higher prevalence of seroreactivity to SARS-CoV-2 in younger, non-white ethnicity, and more deprived groups. We found no significant interaction between the effects of ethnicity and deprivation. Derived from prevalence, the estimated incidence of seroreactivity reflects the trends observed in daily hospitalisations and deaths in London that followed 10 and 13 days later, respectively. We quantified community transmission of SARS-CoV-2 in London, which peaked in late March / early April 2020 with no evidence of community transmission until after January 2020. Our study was not able to determine the date of introduction of the SARS-CoV-2 virus but demonstrates the value of stored antenatal serum samples as a resource for serosurveillance during future outbreaks.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Female / Humans / Pregnancy Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2022 Document Type: Article Affiliation country: Journal.pone.0273966

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Female / Humans / Pregnancy Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2022 Document Type: Article Affiliation country: Journal.pone.0273966